B Hehmke

476 total citations
45 papers, 306 citations indexed

About

B Hehmke is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, B Hehmke has authored 45 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Surgery, 34 papers in Genetics and 27 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in B Hehmke's work include Pancreatic function and diabetes (37 papers), Diabetes and associated disorders (34 papers) and Diabetes Management and Research (20 papers). B Hehmke is often cited by papers focused on Pancreatic function and diabetes (37 papers), Diabetes and associated disorders (34 papers) and Diabetes Management and Research (20 papers). B Hehmke collaborates with scholars based in Germany, Sweden and Denmark. B Hehmke's co-authors include Klaus–Dieter Kohnert, К.-D. Kohnert, Ingrid Klöting, D.K. Schroder, Rolf Odselius, Christian A. Koch, Eckhard Salzsieder, M. Ziegler, B Ziegler and Petra Augstein and has published in prestigious journals such as The Journal of Immunology, Diabetes and Biochemical and Biophysical Research Communications.

In The Last Decade

B Hehmke

39 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Hehmke Germany 11 189 163 143 62 53 45 306
Gong-Qing Shen Japan 7 111 0.6× 127 0.8× 45 0.3× 35 0.6× 137 2.6× 7 350
Sarah Debray Belgium 2 123 0.7× 123 0.8× 65 0.5× 70 1.1× 83 1.6× 5 307
Beth Wapelhorst United States 6 285 1.5× 452 2.8× 203 1.4× 140 2.3× 105 2.0× 7 559
Tatiane C. Nogueira Belgium 8 271 1.4× 208 1.3× 93 0.7× 98 1.6× 237 4.5× 9 538
Anthony J. Pick United States 6 432 2.3× 316 1.9× 266 1.9× 26 0.4× 173 3.3× 10 545
Wilfred Ip Canada 11 237 1.3× 116 0.7× 159 1.1× 35 0.6× 312 5.9× 12 511
Hui‐Pin Hsiao Taiwan 11 119 0.6× 42 0.3× 142 1.0× 27 0.4× 111 2.1× 25 328
Noèlia Téllez Spain 15 326 1.7× 219 1.3× 202 1.4× 34 0.5× 131 2.5× 23 522
Tina Fløyel Denmark 12 204 1.1× 229 1.4× 187 1.3× 79 1.3× 130 2.5× 18 480
Jacek Bocheński Poland 5 69 0.4× 61 0.4× 30 0.2× 37 0.6× 84 1.6× 7 243

Countries citing papers authored by B Hehmke

Since Specialization
Citations

This map shows the geographic impact of B Hehmke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Hehmke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Hehmke more than expected).

Fields of papers citing papers by B Hehmke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Hehmke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Hehmke. The network helps show where B Hehmke may publish in the future.

Co-authorship network of co-authors of B Hehmke

This figure shows the co-authorship network connecting the top 25 collaborators of B Hehmke. A scholar is included among the top collaborators of B Hehmke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Hehmke. B Hehmke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koch, Christian A., et al.. (2019). Correction to: Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties?. Reviews in Endocrine and Metabolic Disorders. 20(2). 251–252. 1 indexed citations
2.
Koch, Christian A., et al.. (2018). Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties?. Reviews in Endocrine and Metabolic Disorders. 19(4). 363–395. 25 indexed citations
3.
Schroder, D.K., B Hehmke, Ingrid Klöting, W. Besch, & S. Schmidt. (2009). Humoral-Mediated Anti-Islet Cytotoxicity in Diabetes-Prone BB/OK Rats-Effect on β-Cell Function and Autologous Islets1, 2). Experimental and Clinical Endocrinology & Diabetes. 95(1). 22–30.
4.
Hehmke, B, et al.. (2009). Autoimmune Reactions in a Patient with Malignant Insulinoma Treated by Multiple Low Dose Streptozotocin*). Experimental and Clinical Endocrinology & Diabetes. 95(1). 77–82. 1 indexed citations
5.
Hehmke, B, et al.. (2009). Impaired β-cell Function in the Chinese Hamster CHIG/Han Subline. Experimental and Clinical Endocrinology & Diabetes. 103(S 02). 66–70.
6.
Witt, Sabine, et al.. (2009). Generation and Partial Characterization of Monoclonal Antibodies Reactive with Islet Cell Antigens. Experimental and Clinical Endocrinology & Diabetes. 89(3). 276–282.
7.
Witt, Sabine, et al.. (2009). Islet Cell Surface Antibodies (ICSA) in Subjects with a Previous Mumps Infection - a Prospective Study over a 4 Year Period. Experimental and Clinical Endocrinology & Diabetes. 90(4). 62–70. 1 indexed citations
8.
Augstein, Petra, A. Dunger, P Heinke, et al.. (2003). Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells. Biochemical and Biophysical Research Communications. 304(2). 378–384. 37 indexed citations
9.
Augstein, Petra, Gerhild Wachlin, Sabine Berg, et al.. (2003). Surface and intracellular Fas expression associated with cytokine-induced apoptosis in rodent islet and insulinoma cells. Journal of Molecular Endocrinology. 30(2). 163–171. 10 indexed citations
10.
Kohnert, К.-D., et al.. (2001). Insulin treatment improves islet function in type 2 diabetic Chinese hamsters. Experimental and Clinical Endocrinology & Diabetes. 109(4). 196–202. 2 indexed citations
11.
12.
Kohnert, К.-D., Ulrika Axcrona, B Hehmke, et al.. (1999). Islet neuronal abnormalities associated with impaired insulin secretion in type 2 diabetes in the Chinese hamster. Regulatory Peptides. 82(1-3). 71–79. 16 indexed citations
13.
Kessler, Jörg, B Hehmke, Ingrid Klöting, & К.-D. Kohnert. (1999). Relationship Between the Histopathology of the Endocrine-Exocrine Pancreas Parenchyma and Beta-Cell Function in the Chinese Hamster CHIG/Han Subline. Pancreas. 19(1). 89–97. 6 indexed citations
14.
15.
Ziegler, B, Silke Lucke, B Hehmke, et al.. (1992). Monoclonal antibody-mediated cytotoxicity against rat Beta cells detected in vitro does not cause Beta-cell destruction in vivo. Diabetologia. 35(7). 608–613. 16 indexed citations
16.
Hehmke, B, Silke Lucke, D.K. Schroder, Ingrid Klöting, & Klaus–Dieter Kohnert. (1990). Complement‐dependent antibody‐mediated cytotoxicity in the spontaneously diabetic BB/OK rat: association with β cell volume density. European Journal of Immunology. 20(5). 1091–1096. 4 indexed citations
17.
Schroder, D.K., et al.. (1990). Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.. PubMed. 15(1). 27–32. 3 indexed citations
18.
Ziegler, M., Susann Teneberg, Sabine Witt, et al.. (1988). Islet beta -cytotoxic monoclonal antibody against glycolipids in experimental diabetes induced by low dose streptozotocin and Freund's adjuvant.. The Journal of Immunology. 140(12). 4144–4150. 8 indexed citations
19.
Ziegler, M., et al.. (1984). Autoimmune response directed to pancreatic beta cells in rats induced by combined treatment with low doses of streptozotocin and complete Freund's adjuvant.. PubMed. 43(5). 675–81. 3 indexed citations
20.
Hehmke, B, et al.. (1984). Absence of cytotoxicity of islet cell surface antibodies in vivo despite complement-mediated cytotoxic effects to islet cells in vitro.. PubMed. 43(5). 663–73. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gong-Qing Shen Breakdown of academic impact, for papers by Sarah Debray Breakdown of academic impact, for papers by Beth Wapelhorst Breakdown of academic impact, for papers by Tatiane C. Nogueira Breakdown of academic impact, for papers by Anthony J. Pick Breakdown of academic impact, for papers by Wilfred Ip Breakdown of academic impact, for papers by Hui‐Pin Hsiao Breakdown of academic impact, for papers by Noèlia Téllez Breakdown of academic impact, for papers by Tina Fløyel Breakdown of academic impact, for papers by Jacek Bocheński
Rankless by CCL
2026